High-risk pulmonary embolism (PE) is a life-threatening disorder associated with high
mortality and morbidity. Most deaths in patients with shock occur within the first few hours …

Although the incidence of venous thromboembolism (VTE) in Asian populations is lower
than in Western countries, the overall burden of VTE in Asia has been considerably …

Background: Venous thromboembolism (VTE) has a long-term risk of recurrence, which can
be prevented by anticoagulation therapy. Methods and Results: The COMMAND VTE …

Abstract Background The global EINSTEIN DVT and PE studies compared rivaroxaban (15
mg twice daily for 3 weeks followed by 20 mg once daily) with enoxaparin/vitamin K …

Background: Anticoagulation is recommended as standard of care for venous
thromboembolism (VTE)(pulmonary embolism [PE]/deep vein thrombosis [DVT]), for which …

Venous thromboembolism (VTE), manifesting as either deep vein thrombosis or pulmonary
embolism, is common worldwide including in Japan. The number of patients clinically …

Gender differences in patients with acute pulmonary embolism (APE) remain unclear and
controversial. We aimed to understand the gender differences in patients with APE treated in …

The prognosis of patients with cancer has improved due to an early diagnosis of cancer and
advances in cancer treatment. There are emerging reports on cardiotoxicity in cancer …

Background: There is insufficient real-world data on the current status of Japanese patients
with venous thromboembolism (VTE) or its treatment and prevention with rivaroxaban …

Abstract Background Although the Khorana venous thromboembolism (VTE) risk score
(KRS) is well recognized as a simple VTE risk assessment method in patients with cancer …